GeoVax Labs Inc.

GeoVax Labs Inc.
Stock Exchange Other OTC
EPS
$6.91
Market Cap
$384.3 K
Shares Outstanding
610 K
Public Float
251.91 M

Profile

Address
1900 Lake Park Drive
Smyrna Georgia 30080
United States
Employees -
Website http://www.geovax.com
Updated 07/08/2019
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines using its novel vaccine platform. It focuses on human immunodeficiency virus, zika virus, hemorrhagic fever viruses, and malaria. The company was founded by Harriet Latham Robinson and Donald G.

Financials

View All
Created with Highcharts 5.0.14GeoVax Labs Inc.Net Income. Fiscal year is January-December. All values USD Thousands.2 2842 2842 7332 7332 6892 6893 2713 2712 1702 1702 5602 56020132014201520162017201801k2k3k4k
Created with Highcharts 5.0.14GeoVax Labs Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.2 4172 4178838834284288288281 0751 075963963201320142015201620172018050010001500200025003000

Robert T. McNally
Director
Harriet Latham Robinson
Director